Q&A with Verici Dx #VRCI CEO, Sara Barrington

Developing world beating medical science goes hand-in-hand with
Verici DX #VRCI. A next generation, immuno-diagnostics firm, specialising in kidney transplants.

In this interview, CEO Sara Barrington takes Vox Markets through today’s upbeat interims, including the:

08:10 Positive trial results of the company’s 2 lead tests Tuteva (start) and Clarava
13:05 Broader validation of its innovative RNA technology platform
16:55 Theoretical size of the addressable market
19:55 Next steps for 3rd Protega diagnostic
20:55 Significance of Illumina collaboration
25:15 Cash runway ahead
26:45 Future newsflow

You might like

© 2022 Stockmark.it The Latest StockMarket News and Interviews